LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 58

Search options

  1. Article ; Online: The clinical relevance of complex regional pain syndrome type I: The Emperor's New Clothes.

    Borchers, Andrea T / Gershwin, M Eric

    Autoimmunity reviews

    2017  Volume 16, Issue 1, Page(s) 22–33

    Abstract: The management of patients with chronic pain is a nearly daily challenge to rheumatologists, neurologists, orthopedic surgeons, pain specialists and indeed a issue in nearly every clinical practice. Among the myriad of causes of pain are often included a ...

    Abstract The management of patients with chronic pain is a nearly daily challenge to rheumatologists, neurologists, orthopedic surgeons, pain specialists and indeed a issue in nearly every clinical practice. Among the myriad of causes of pain are often included a unique syndrome, generally referred to as complex regional pain syndrome type I (CRPS). Unfortunately CRPS I has become a catch all phase and there are serious questions on whether it exists at all; this has led to an extraordinary number of poorly defined diagnostic criteria. It has also led to an etiologic quagmire that includes features as diverse as autoimmunity to simple trauma. These, in turn, have led to overdiagnosis and often overzealous use of pain medications, including narcotics. In a previous paper, we raised the issue of whether CRPS type I reflected a valid diagnosis. Indeed, the diagnostic criteria for CRPS I, and therefore the diagnosis itself, is unreliable for a number of reasons: 1) the underlying pathophysiology of the signs and symptoms of CPRS I are not biologically plausible; 2) there are no consistent laboratory or imaging testing available; 3) the signs and symptoms fluctuate over time without a medical explanation; 4) the definitions of most studies are derived from statistical analysis with little consideration to required sample size, i.e. power calculations; 5) interobserver reliability in the assessment of the signs and symptoms are often only fair to moderate, and agreement on the diagnosis of "CRPS I" is poor. Even physicians who still believe in the concept of "CRPS I" admit that it is vastly overdiagnosed and has become a diagnosis of last resort, often without a complete differential diagnosis and an alternative explanation. Finally, one of the most convincing arguments that there is no clinical entity as "CRPS I" comes from the enormous heterogeneity in sign and symptom profiles and the heterogeneity of pathophysiological mechanisms postulated. This observation is underscored by the diversity of responses among "CRPS I" patients to essentially all treatment modalities. It has even led to the concept that the signs and symptoms of CRPS can spread throughout the body, as if it is an infectious disease, without any medical plausible explanation. If true progress is to be made in helping patients with pain, it will require entirely new and different concepts and abandoning CRPS I as a legitimate diagnosis.
    MeSH term(s) Animals ; Complex Regional Pain Syndromes/diagnosis ; Complex Regional Pain Syndromes/therapy ; Diagnosis, Differential ; Humans ; Reproducibility of Results ; Treatment Outcome
    Language English
    Publishing date 2017-01
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2016.09.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Fibromyalgia: A Critical and Comprehensive Review.

    Borchers, Andrea T / Gershwin, M Eric

    Clinical reviews in allergy & immunology

    2015  Volume 49, Issue 2, Page(s) 100–151

    Abstract: Fibromyalgia is a disorder that is part of a spectrum of syndromes that lack precise classification. It is often considered as part of the global overview of functional somatic syndromes that are otherwise medically unexplained or part of a somatization ... ...

    Abstract Fibromyalgia is a disorder that is part of a spectrum of syndromes that lack precise classification. It is often considered as part of the global overview of functional somatic syndromes that are otherwise medically unexplained or part of a somatization disorder. Patients with fibromyalgia share symptoms with other functional somatic problems, including issues of myalgias, arthralgias, fatigue and sleep disturbances. Indeed, there is often diagnostic and classification overlap for the case definitions of a variety of somatization disorders. Fibromyalgia, however, is a critically important syndrome for physicians and scientists to be aware of. Patients should be taken very seriously and provided optimal care. Although inflammatory, infectious, and autoimmune disorders have all been ascribed to be etiological events in the development of fibromyalgia, there is very little data to support such a thesis. Many of these disorders are associated with depression and anxiety and may even be part of what has been sometimes called affected spectrum disorders. There is no evidence that physical trauma, i.e., automobile accidents, is associated with the development or exacerbation of fibromyalgia. Treatment should be placed on education, patient support, physical therapy, nutrition, and exercise, including the use of drugs that are approved for the treatment of fibromyalgia. Treatment should not include opiates and patients should not become poly pharmacies in which the treatment itself can lead to significant morbidities. Patients with fibromyalgia are living and not dying of this disorder and positive outlooks and family support are key elements in the management of patients.
    MeSH term(s) Analgesics, Opioid ; Animals ; Contraindications ; Diagnosis, Differential ; Fatigue Syndrome, Chronic/diagnosis ; Fibromyalgia/diagnosis ; Fibromyalgia/etiology ; Fibromyalgia/therapy ; Humans ; Patient Education as Topic ; Physical Therapy Modalities ; Polypharmacy ; Social Support
    Chemical Substances Analgesics, Opioid
    Language English
    Publishing date 2015-10
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1239045-8
    ISSN 1559-0267 ; 1080-0549
    ISSN (online) 1559-0267
    ISSN 1080-0549
    DOI 10.1007/s12016-015-8509-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Mold and Human Health: a Reality Check.

    Borchers, Andrea T / Chang, Christopher / Eric Gershwin, M

    Clinical reviews in allergy & immunology

    2017  Volume 52, Issue 3, Page(s) 305–322

    Abstract: There are possibly millions of mold species on earth. The vast majority of these mold spores live in harmony with humans, rarely causing disease. The rare species that does cause disease does so by triggering allergies or asthma, or may be involved in ... ...

    Abstract There are possibly millions of mold species on earth. The vast majority of these mold spores live in harmony with humans, rarely causing disease. The rare species that does cause disease does so by triggering allergies or asthma, or may be involved in hypersensitivity diseases such as allergic bronchopulmonary aspergillosis or allergic fungal sinusitis. Other hypersensitivity diseases include those related to occupational or domiciliary exposures to certain mold species, as in the case of Pigeon Breeder's disease, Farmer's lung, or humidifier fever. The final proven category of fungal diseases is through infection, as in the case of onchomycosis or coccidiomycosis. These diseases can be treated using anti-fungal agents. Molds and fungi can also be particularly important in infections that occur in immunocompromised patients. Systemic candidiasis does not occur unless the individual is immunodeficient. Previous reports of "toxic mold syndrome" or "toxic black mold" have been shown to be no more than media hype and mass hysteria, partly stemming from the misinterpreted concept of the "sick building syndrome." There is no scientific evidence that exposure to visible black mold in apartments and buildings can lead to the vague and subjective symptoms of memory loss, inability to focus, fatigue, and headaches that were reported by people who erroneously believed that they were suffering from "mycotoxicosis." Similarly, a causal relationship between cases of infant pulmonary hemorrhage and exposure to "black mold" has never been proven. Finally, there is no evidence of a link between autoimmune disease and mold exposure.
    MeSH term(s) Allergens/immunology ; Environmental Exposure/adverse effects ; Fungi/immunology ; Hemorrhage ; Host-Pathogen Interactions ; Humans ; Hypersensitivity/immunology ; Immunocompromised Host ; Mycoses/immunology ; Mycotoxicosis
    Chemical Substances Allergens
    Language English
    Publishing date 2017-03-16
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1239045-8
    ISSN 1559-0267 ; 1080-0549
    ISSN (online) 1559-0267
    ISSN 1080-0549
    DOI 10.1007/s12016-017-8601-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: The Basis of Structure/Function Claims of Nutraceuticals.

    Borchers, Andrea T / Keen, Carl L / Gershwin, M Eric

    Clinical reviews in allergy & immunology

    2016  Volume 51, Issue 3, Page(s) 370–382

    Abstract: In the United States, as in most of the world, there are large numbers of nutraceuticals that are sold and which people take to boost their immune response. There are, in addition, almost an equal number of products sold to reduce allergies. However, ... ...

    Abstract In the United States, as in most of the world, there are large numbers of nutraceuticals that are sold and which people take to boost their immune response. There are, in addition, almost an equal number of products sold to reduce allergies. However, very few consumers, and indeed physicians, are aware of what a structure/function claim is. Structure/function claims are labeling claims that can be used to describe the potential effects of a dietary ingredient or similar substance on the structure or function of the human body. This category of claims was created by legislation contained in the Dietary Supplement Health and Education Act. The intent was to supply consumers with reasonably substantiated information that would allow them to make educated choices about their diet and health. They were not intended to have the same weight and substantiation as the claims made for conventional prescription pharmaceuticals. Rather, they were proposed to fill the gap between consumer desire for over-the-counter supplements and foods, and rigorous and generally more potent and potentially "toxic" prescription medications. The legally mandated disclaimer, stating that the U.S. Food and Drug Administration has not evaluated the structure/function claim, often leads to misinterpretation. While there should be a biologic premise underlying the claim, there is not an absolute requirement for a conventional rigorous placebo-controlled dose response trial. While this may not be the clinical standard that a typical scientific oriented society might desire, it reflects the attempts of the FDA to find common grounds and to allow consumers to use products that are generally considered as safe based on historical use and biologic comparisons. The logic of, indeed need for, structure/function claims is straightforward; however, of equal importance is that nutraceuticals should be properly labeled, have accuracy in their ingredients, be free of contamination, be safe, and have a reasonable body of data that supports their efficacy.
    MeSH term(s) Consumer Health Information ; Dietary Supplements/analysis ; Dietary Supplements/history ; Dietary Supplements/standards ; Drug Labeling ; Food ; History, 20th Century ; Humans ; Law Enforcement ; Legislation, Drug ; United States ; United States Food and Drug Administration
    Language English
    Publishing date 2016-12
    Publishing country United States
    Document type Historical Article ; Journal Article ; Review
    ZDB-ID 1239045-8
    ISSN 1559-0267 ; 1080-0549
    ISSN (online) 1559-0267
    ISSN 1080-0549
    DOI 10.1007/s12016-016-8536-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment.

    Borchers, Andrea T / Gershwin, M Eric

    Autoimmunity reviews

    2012  Volume 11, Issue 6-7, Page(s) A544–54

    Abstract: Giant cell arteritis is a chronic vasculitis affecting large and medium-sized arteries, most commonly the temporal and other cranial arteries. Temporal artery biopsy has long been the gold standard for establishing the diagnosis of giant cell arteritis. ... ...

    Abstract Giant cell arteritis is a chronic vasculitis affecting large and medium-sized arteries, most commonly the temporal and other cranial arteries. Temporal artery biopsy has long been the gold standard for establishing the diagnosis of giant cell arteritis. There is growing evidence that simultaneous color Doppler and duplex ultrasonography of temporal arteries of GCA patients represents a valid alternative for this somewhat invasive procedure. Ultrasonography and other imaging modalities such as magnetic resonance imaging and positron emission tomography have also provided evidence that involvement of the aorta and its proximal branches is much more common in giant cell arteritis than previously appreciated; it will be important to clarify whether these patients need to be treated more aggressively. It has long been known that patients with giant cell arteritis face a markedly increased risk of developing aortic aneurysms and of dying from aortic dissection. This raises important questions as to whether patients should be screened regularly for extra-cranial large-vessel involvement and whether and how treatment of patients with positive screening results should be adjusted. In this review we discuss the pathophysiology of this disease and also the issues of epidemiology and sex differences.
    MeSH term(s) Aorta/pathology ; Aortic Aneurysm/pathology ; Aspirin/therapeutic use ; Azathioprine/adverse effects ; Azathioprine/therapeutic use ; Dendritic Cells/immunology ; Female ; Giant Cell Arteritis/diagnosis ; Giant Cell Arteritis/epidemiology ; Giant Cell Arteritis/physiopathology ; Humans ; Macrophages/immunology ; Magnetic Resonance Angiography ; Male ; Methotrexate/adverse effects ; Methotrexate/therapeutic use ; Positron-Emission Tomography/methods ; Sex Factors ; T-Lymphocytes/immunology ; Temporal Arteries/diagnostic imaging ; Temporal Arteries/pathology ; Ultrasonography/methods
    Chemical Substances Azathioprine (MRK240IY2L) ; Aspirin (R16CO5Y76E) ; Methotrexate (YL5FZ2Y5U1)
    Language English
    Publishing date 2012-05
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2012.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Transverse myelitis.

    Borchers, Andrea T / Gershwin, M Eric

    Autoimmunity reviews

    2012  Volume 11, Issue 3, Page(s) 231–248

    Abstract: Acute transverse myelitis (ATM) is an etiologically heterogeneous syndrome with acute or subacute onset, in which inflammation of the spinal cord results in neurologic deficits, manifesting as weakness, sensory loss and autonomic dysfunction. It is ... ...

    Abstract Acute transverse myelitis (ATM) is an etiologically heterogeneous syndrome with acute or subacute onset, in which inflammation of the spinal cord results in neurologic deficits, manifesting as weakness, sensory loss and autonomic dysfunction. It is frequently associated with infectious or systemic autoimmune diseases, but its etiology remains unknown in a substantial portion of cases, which are classified as idiopathic. Unifying diagnostic criteria for idiopathic and disease-associated ATM were proposed in 2002. Although they have been applied to a few cohorts of patients, the limited information provided in the relevant publications has not yet yielded many new insights on the clinical characteristics, disease course, and outcome of adult patients with idiopathic ATM compared to older studies that did not always distinguish between the various etiologies of ATM. There is, however, some new epidemiological data indicating that the incidence of idiopathic ATM is considerably higher, and the female preponderance greater, than previously recognized. In addition, new data on children with ATM show that the prognosis in pediatric patients is not always as benign as previous studies had indicated. The combination of ATM and optic neuritis characterize Devic's syndrome or neuromyelitis optica (NMO). A seminal discovery was the identification of an antibody that is a specific marker not only for NMO, but also of some of its characteristic manifestations in isolation, including longitudinally extensive TM. This has resulted in the proposal that all of the disorders that are associated with NMO-IgG positivity constitute part of an NMO spectrum of disorders. This antibody recognizes aquaporin-4, which represents the most abundant water channel of the central nervous system. There is growing evidence that the antibodies targeting this channel protein have pathogenic potential, thereby providing insights into the possible pathogenetic mechanisms of at least one type of ATM.
    MeSH term(s) Adult ; Aquaporin 4/immunology ; Autoantibodies/immunology ; Autoantibodies/metabolism ; Autoantigens/immunology ; Child ; Cytotoxicity, Immunologic ; Humans ; Myelitis, Transverse/diagnosis ; Myelitis, Transverse/immunology ; Spinal Cord/immunology
    Chemical Substances Aquaporin 4 ; Autoantibodies ; Autoantigens
    Language English
    Publishing date 2012-01
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2011.05.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Sociological differences between women and men: implications for autoimmunity.

    Borchers, Andrea T / Gershwin, M Eric

    Autoimmunity reviews

    2012  Volume 11, Issue 6-7, Page(s) A413–21

    Abstract: There are an enormous number of incorrect stereotypes that characterize the differences between women and men. Indeed, nearly all of these stereotypes are based on cultural inaccuracies and faulty data without consideration of biology and the distinct ... ...

    Abstract There are an enormous number of incorrect stereotypes that characterize the differences between women and men. Indeed, nearly all of these stereotypes are based on cultural inaccuracies and faulty data without consideration of biology and the distinct sociological differences between genders. Sociological differences are those that relate to the development, structure, interaction and behavior of organized groups of human beings, or societies, and their values and beliefs. Gender is a social construct referring "to the culturally and historically based differences in the roles, attitudes and behaviors of men and women" ([1], p.1) as shaped by norms and stereotypes. Sex, on the other hand, serves to classify living things according to their reproductive organs and functions assigned by chromosomal complement (according to the US Institute of Medicine) and the physical and biological characteristics arising from these organs and functions. The two terms are generally viewed as dichotomous; however, they are closely intertwined in as yet hardly understood ways, and it is frequently difficult to distinguish between them since gendered life experiences can have profound effects on body structure and function [2]. In this review, we will examine to what extent gender roles and stereotypes shape the daily lives of women in their roles as students, employees, wives, and mothers and their health. These data have implications for the etiology of autoimmunity and also for differences in the natural history of disease.
    MeSH term(s) Autoimmune Diseases ; Autoimmunity ; Female ; Gender Identity ; Humans ; Male ; Sex Factors ; Sociobiology ; Socioeconomic Factors ; Stereotyping
    Language English
    Publishing date 2012-05
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2011.11.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: The immune response in Coccidioidomycosis.

    Borchers, Andrea T / Gershwin, M Eric

    Autoimmunity reviews

    2010  Volume 10, Issue 2, Page(s) 94–102

    Abstract: With the increasing use of biologics, clinical rheumatologists are becoming very well acquainted with opportunistic infections, including tuberculosis, histoplasmosis and Coccidiomycosis. In the great valleys of California as well as several other hot ... ...

    Abstract With the increasing use of biologics, clinical rheumatologists are becoming very well acquainted with opportunistic infections, including tuberculosis, histoplasmosis and Coccidiomycosis. In the great valleys of California as well as several other hot spots in the Southern areas of the United States and select pockets in South America, valley fever, also known as Coccidiomycosis, is an endemic infection. The vast majority of patients are asymptomatic following exposure, but are at risk for clinical disease in the case of immunosuppression. Additionally, although 60% of patients with infections are completely asymptomatic, nearly all patients have immunological evidence of exposure. Within some communities in the central valley of California, sero conversion approaches 100%, fortunately the vast majority remain asymptomatic. In this review we will place the context of the immune response to Coccidiomycosis in perspective and discuss not only the lymphoid response, but also recent data on antigenic analysis and bioinformatics of Coccidioides. This information is significant not only for a better understanding of Coccidiomycosis, but will also have utility in the management of patients within areas of the world who are treated with the biologics for autoimmune disease.
    MeSH term(s) Animals ; B-Lymphocytes/immunology ; Coccidioides/immunology ; Coccidioidomycosis/epidemiology ; Coccidioidomycosis/immunology ; Humans ; Lymphocyte Activation/immunology ; Mice ; T-Lymphocytes/immunology
    Language English
    Publishing date 2010-12
    Publishing country Netherlands
    Document type Journal Article ; Review
    ZDB-ID 2144145-5
    ISSN 1873-0183 ; 1568-9972
    ISSN (online) 1873-0183
    ISSN 1568-9972
    DOI 10.1016/j.autrev.2010.08.010
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Lyme disease: a rigorous review of diagnostic criteria and treatment.

    Borchers, Andrea T / Keen, Carl L / Huntley, Arthur C / Gershwin, M Eric

    Journal of autoimmunity

    2015  Volume 57, Page(s) 82–115

    Abstract: Lyme disease was originally identified in Lyme, Connecticut, based upon an unusual cluster of what appeared to be patients with juvenile rheumatoid arthritis. It was subsequently identified as a new clinical entity originally called Lyme arthritis based ... ...

    Abstract Lyme disease was originally identified in Lyme, Connecticut, based upon an unusual cluster of what appeared to be patients with juvenile rheumatoid arthritis. It was subsequently identified as a new clinical entity originally called Lyme arthritis based on the observation that arthritis was a major clinical feature. However, Lyme arthritis is now called Lyme disease based upon the understanding that the clinical features include not only arthritis, but also potential cardiac, dermatologic and neurologic findings. Lyme disease typically begins with an erythematous rash called erythema migrans (EM). Approximately 4-8% of patients develop cardiac, 11% develop neurologic and 45-60% of patients manifest arthritis. The disease is transmitted following exposure to a tick bite containing a spirochete in a genetically susceptible host. There is considerable data on spirochetes, including Borrelia burgdorferi (Bb), the original bacteria identified in this disease. Lyme disease, if an organism had not been identified, would be considered as a classic autoimmune disease and indeed the effector mechanisms are similar to many human diseases manifest as loss of tolerance. The clinical diagnosis is highly likely based upon appropriate serology and clinical manifestations. However, the serologic features are often misinterpreted and may have false positives if confirmatory laboratory testing is not performed. Antibiotics are routinely and typically used to treat patients with Lyme disease, but there is no evidence that prolonged or recurrent treatment with antibiotics change the natural history of Lyme disease. Although there are animal models of Lyme disease, there is no system that faithfully recapitulates the human disease. Further research on the effector mechanisms that lead to pathology in some individuals should be further explored to develop more specific therapy.
    MeSH term(s) Animals ; Anti-Bacterial Agents/therapeutic use ; Borrelia/classification ; Borrelia/drug effects ; Borrelia/physiology ; Host-Pathogen Interactions/drug effects ; Humans ; Insect Vectors/classification ; Insect Vectors/microbiology ; Ixodes/classification ; Ixodes/microbiology ; Lyme Disease/diagnosis ; Lyme Disease/drug therapy ; Lyme Disease/microbiology ; Skin Diseases, Bacterial/diagnosis ; Skin Diseases, Bacterial/drug therapy ; Skin Diseases, Bacterial/microbiology ; Treatment Outcome
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2015-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 639452-8
    ISSN 1095-9157 ; 0896-8411
    ISSN (online) 1095-9157
    ISSN 0896-8411
    DOI 10.1016/j.jaut.2014.09.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Respiratory syncytial virus--a comprehensive review.

    Borchers, Andrea T / Chang, Christopher / Gershwin, M Eric / Gershwin, Laurel J

    Clinical reviews in allergy & immunology

    2013  Volume 45, Issue 3, Page(s) 331–379

    Abstract: Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of childhood and is associated with significant morbidity and mortality. Although there have been extensive studies of epidemiology, clinical manifestations, diagnostic ...

    Abstract Respiratory syncytial virus (RSV) is amongst the most important pathogenic infections of childhood and is associated with significant morbidity and mortality. Although there have been extensive studies of epidemiology, clinical manifestations, diagnostic techniques, animal models and the immunobiology of infection, there is not yet a convincing and safe vaccine available. The major histopathologic characteristics of RSV infection are acute bronchiolitis, mucosal and submucosal edema, and luminal occlusion by cellular debris of sloughed epithelial cells mixed with macrophages, strands of fibrin, and some mucin. There is a single RSV serotype with two major antigenic subgroups, A and B. Strains of both subtypes often co-circulate, but usually one subtype predominates. In temperate climates, RSV infections reflect a distinct seasonality with onset in late fall or early winter. It is believed that most children will experience at least one RSV infection by the age of 2 years. There are several key animal models of RSV. These include a model in mice and, more importantly, a bovine model; the latter reflects distinct similarity to the human disease. Importantly, the prevalence of asthma is significantly higher amongst children who are hospitalized with RSV in infancy or early childhood. However, there have been only limited investigations of candidate genes that have the potential to explain this increase in susceptibility. An atopic predisposition appears to predispose to subsequent development of asthma and it is likely that subsequent development of asthma is secondary to the pathogenic inflammatory response involving cytokines, chemokines and their cognate receptors. Numerous approaches to the development of RSV vaccines are being evaluated, as are the use of newer antiviral agents to mitigate disease. There is also significant attention being placed on the potential impact of co-infection and defining the natural history of RSV. Clearly, more research is required to define the relationships between RSV bronchiolitis, other viral induced inflammatory responses, and asthma.
    MeSH term(s) Animals ; Humans ; Mice ; Respiratory Syncytial Virus Infections/diagnosis ; Respiratory Syncytial Virus Infections/epidemiology ; Respiratory Syncytial Virus Infections/etiology ; Respiratory Syncytial Virus Infections/prevention & control ; Respiratory Syncytial Virus Infections/therapy ; Respiratory Syncytial Virus Vaccines/immunology ; Respiratory Syncytial Virus, Human/classification ; Respiratory Syncytial Virus, Human/physiology ; Respiratory Syncytial Viruses/classification ; Respiratory Syncytial Viruses/physiology
    Chemical Substances Respiratory Syncytial Virus Vaccines
    Keywords covid19
    Language English
    Publishing date 2013-04-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1239045-8
    ISSN 1559-0267 ; 1080-0549
    ISSN (online) 1559-0267
    ISSN 1080-0549
    DOI 10.1007/s12016-013-8368-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top